— Know what they know.
Not Investment Advice

ARVN NASDAQ

Arvinas, Inc.
1W: -2.7% 1M: -0.8% 3M: -9.4% YTD: -35.0% 1Y: -19.1% 3Y: -49.8% 5Y: -91.0%
$7.45
+0.14 (+1.92%)
Pre-Market: $7.58 (+0.13, +1.74%)
Weekly Expected Move ±7.7%
$6 $7 $7 $8 $8
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 47 · $480.7M mcap · 57M float · 1.38% daily turnover · Short 55% of daily vol
Credit Risk of going bust: lower than 89% of companies Debt: 1.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Arvinas, Inc. would be worth roughly what it owes.
Total debt $8.2M against a stock market value of $480.7M.
Distance to default 12.91 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $350K (short-term plus half of long-term), stock volatility 55.2%; Altman Z'' 3.51. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$718M -34.2% ▼
5Y CAGR: +0.0%
Total Liabilities
$284M -46.4% ▼
5Y CAGR: +30.4%
Shareholders Equity
$434M -22.8% ▼
5Y CAGR: -7.5%
Cash & Investments
$685M -34.1% ▼
5Y CAGR: -0.1%
Total Debt
$8M -12.4% ▼
5Y CAGR: +15.7%
Net Debt
-$134M -48.0% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$108M$81M$312M$100M$143M
Short-Term Investments$1.4B$1.1B$949M$939M$542M
Cash & ST Investments$1.5B$1.2B$1.3B$1.0B$685M
Net Receivables$26M$8M$7M$14M$6M
Inventory$0$0$0$0$0
Other Current Assets$4M$27M$12M$14M$9M
Total Current Assets$1.6B$1.2B$1.3B$1.1B$701M
Property, Plant & Equip.$17M$18M$14M$16M$13M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$12M$11M$10M$8M$4M
Total Non-Current Assets$29M$29M$24M$24M$17M
Total Assets$1.6B$1.3B$1.3B$1.1B$718M
— Liabilities —
Accounts Payable$31M$6M$18M$13M$24M
Short-Term Debt$0$0$0$0$0
Deferred Revenue$206M$219M$163M$156M$71M
Other Current Liabilities$12M$19M$48M$0$40M
Total Current Liabilities$262M$295M$257M$230M$142M
Long-Term Debt$1M$1M$800K$600K$400K
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$538M$409M$388M$300M$142M
Total Liabilities$800M$704M$645M$530M$284M
— Equity —
Common Stock$0$100K$100K$100K$100K
Retained Earnings-$683M-$965M-$1.3B-$1.5B-$1.6B
Accumulated OCI-$5M-$19M-$3M$1M$1M
Total Stockholders Equity$782M$565M$660M$562M$434M
Total Liabilities & Equity$1.6B$1.3B$1.3B$1.1B$718M
— Key Metrics —
Total Debt$5M$6M$3M$10M$8M
Net Debt-$103M-$76M-$308M-$91M-$134M
Total Investments$1.4B$1.1B$949M$939M$542M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms